Diffusely abnormal white matter in multiple sclerosis.
DAWM
MRI
brain
diffusely abnormal white matter
multiple sclerosis
Journal
Journal of neuroimaging : official journal of the American Society of Neuroimaging
ISSN: 1552-6569
Titre abrégé: J Neuroimaging
Pays: United States
ID NLM: 9102705
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
17
10
2021
received:
08
10
2021
accepted:
18
10
2021
pubmed:
10
11
2021
medline:
19
3
2022
entrez:
9
11
2021
Statut:
ppublish
Résumé
MRI enables detailed in vivo depiction of multiple sclerosis (MS) pathology. Localized areas of MS damage, commonly referred to as lesions, or plaques, have been a focus of clinical and research MRI studies for over four decades. A nonplaque MRI abnormality which is present in at least 25% of MS patients but has received far less attention is diffusely abnormal white matter (DAWM). DAWM has poorly defined boundaries and a signal intensity that is between normal-appearing white matter and classic lesions on proton density and T
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
5-16Informations de copyright
© 2021 American Society of Neuroimaging.
Références
The Multiple Sclerosis International Federation. Atlas of MS. 3rd ed. Available at: https://www.atlasofms.org/map/global/epidemiology/number-of-people-with-ms Accessed September 28, 2021
Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018;17:162-73.
Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981;2:1063-6.
Compston A, Lassmann H, McDonald I. The story of multiple sclerosis. In: Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, K Smith and H Wekerle, editors. McAlpine's multiple sclerosis. Philadelphia, PA: Churchill Livingstone Elsevier; 2005 pp. 3-68.
Moore GRW, Stadelmann-Nessler C. Demyelinating diseases. In: Love S, Budka H, Ironside JW, Perry A, editors. Greenfield's neuropathology. 9th ed. Boca Raton, FL: Taylor and Francis (CRC Press); 2015, pp. 1297-412.
Ferguson B, Matyszak MK, Esiri MM, Perry VH. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-9.
Lassmann H, Bruck W, Lucchinetti C, Rodriguez M. Remyelination in multiple sclerosis. Mult Scler 1997;3:133-6.
Miller DH, Grossman RI, Reingold SC, McFarland HF. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 1998;121:3-24.
Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol 2002;15:239-45.
Allen IV. Demyelinating diseases. In: Adams J, Corsellis J, Duchen L, editors. Greenfield's neuropathology. New York: John Wiley and Sons; 1984, pp. 338-84.
Evangelou N, Esiri MM, Smith S, Palace J, Matthews PM. Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis. Ann Neurol 2000;47:391-5.
Kirk J, Plumb J, Mirakhur M, McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 2003;201:319-27.
Plumb J, McQuaid S, Mirakhur M, Kirk J. Abnormal endothelial tight junctions in active lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol 2002;12:154-69.
De Stefano N, Narayanan S, Francis SJ, Smith S, Mortilla M, Tartaglia MC, et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. Arch Neurol 2002;59:1565-71.
Filippi M, Campi A, Dousset V, Baratti C, Martinelli V, Canal N, et al. A magnetization transfer imaging study of normal-appearing white matter in multiple sclerosis. Neurology 1995;45:478-82.
Laule C, Vavasour IM, Moore GRW, Oger J, Li DK, Paty DW, et al. Water content and myelin water fraction in multiple sclerosis: a T2 relaxation study. J Neurol 2004;251:284-93.
Faizy TD, Thaler C, Kumar D, Sedlacik J, Broocks G, Grosser M, et al. Heterogeneity of multiple sclerosis lesions in multislice myelin water imaging. PLoS One 2016;11:e0151496.
Kitzler HH, Su J, Zeineh M, Harper-Little C, Leung A, Kremenchutzky M, et al. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI. Neuroimage 2012;59:2670-7.
Khaleeli Z, Sastre-Garriga J, Ciccarelli O, Miller DH, Thompson AJ. Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry 2007;78:1076-82.
Abel S, Vavasour I, Lee LE, Johnson P, Ackermans N, Chan J, et al. Myelin damage in normal appearing white matter contributes to impaired cognitive processing speed in multiple sclerosis. J Neuroimaging 2020;30:205-11.
Zhao GJ, Li DKB, Cheng Y, Wang XY, Paty DW. MRI dirty-appearing white matter in MS (Abstract). Neurology 2000;54(Suppl 3):A121.
Vertinsky AT, Li DKB, Vavasour IM, Miropolsky V, Zhao G, Zhao Y, et al. Diffusely abnormal white matter, T(2) burden of disease, and brain volume in relapsing-remitting multiple sclerosis. J Neuroimaging 2019;29:151-9.
Vavasour IM, Becquart P, Gill J, Zhao G, Yik JT, Traboulsee A, et al. Diffusely abnormal white matter in clinically isolated syndrome is associated with parenchymal loss and elevated neurofilament levels (Abstract). Mult Scler 2021;27(Suppl 2):P454.
Zhao GJ, Li DKB, Cheng Y, Wang X, Paty DW, UBC MS/MRI Research Group. Active multiple sclerosis lesions occur in dirty-appearing white matter as detected by serial magnetic resonance imaging (Abstract). Ann Neurol 1998;3:465.
Fazekas F, Barkhof F, Filippi M, Grossman RI, Li DK, McDonald WI, et al. The contribution of magnetic resonance imaging to the diagnosis of multiple sclerosis. Neurology 1999;53:448-56.
Ge Y, Grossman RI, Babb JS, He J, Mannon LJ. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis. AJNR Am J Neuroradiol 2003;24:1935-40.
Zhao G, Li DKB, Cheng Y, Paty DW; UBC MS/MRI Research Group, PRISMS Study Group. Possible prognostic significance of dirty-appearing white matter on MRI in multiple sclerosis (Abstract). Mult Scler 2003;9(Suppl 1):S61.
West J, Aalto A, Tisell A, Leinhard OD, Landtblom AM, Smedby Ö, et al. Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR. PLoS One 2014;9:e95161.
Papadaki E, Mastorodemos V, Panou T, Spyridaki E, Kavroulakis E, Kalaitzakis G, et al. T2 relaxometry evidence of microstructural changes in diffusely abnormal white matter in relapsing-remitting multiple sclerosis and clinically isolated syndrome: impact on visuomotor performance. J Magn Reson Imaging 2021;54:1077-87.
Filippi M, Rocca MA. Dirty-appearing white matter: a disregarded entity in multiple sclerosis. AJNR Am J Neuroradiol 2010;31:390-1.
Chen SC, Chung HW, Liou M. Measurement of volumetric lesion load in multiple sclerosis: moving from normal- to dirty-appearing white matter. AJNR Am J Neuroradiol 2003;24:1929-30.
Papanikolaou N, Papadaki E, Karampekios S, Spilioti M, Maris T, Prassopoulos P, et al. T2 relaxation time analysis in patients with multiple sclerosis: correlation with magnetization transfer ratio. Eur Radiol 2004;14:115-22.
Karampekios S, Papanikolaou N, Papadaki E, Maris T, Uffman K, Spilioti M, et al. Quantification of magnetization transfer rate and native T1 relaxation time of the brain: correlation with magnetization transfer ratio measurements in patients with multiple sclerosis. Neuroradiology 2005;47:189-96.
Holmes RD, Vavasour IM, Greenfield J, Zhao G, Lee JS, Moore GRW, et al. Nonlesional diffusely abnormal appearing white matter in clinically isolated syndrome: prevalence, association with clinical and MRI features, and risk for conversion to multiple sclerosis. J Neuroimaging 2021;31:981-94.
Schima W, Wimberger D, Schneider B, Stiglbauer R, Asenbaum S, Imhof H. [The importance of magnetic field strength in the MR diagnosis of multiple sclerosis: a comparison of 0.5 and 1.5 T]. Rofo 1993;158:368-71.
Ge Y, Udupa JK, Nyúl LG, Wei L, Grossman RI. Numerical tissue characterization in MS via standardization of the MR image intensity scale. J Magn Reson Imaging 2000;12:715-21.
Kitzler HH, Wahl H, Eisele JC, Kuhn M, Schmitz-Peiffer H, Kern S, et al. Multi-component relaxation in clinically isolated syndrome: lesion myelination may predict multiple sclerosis conversion. Neuroimage Clin 2018;20:61-70.
Filip P, Svatkova A, Carpenter AF, Eberly LE, Nestrasil I, Nissi MJ, et al. Rotating frame MRI relaxations as markers of diffuse white matter abnormalities in multiple sclerosis. Neuroimage Clin 2020;26:102234.
Maranzano J, Dadar M, Zhernovaia M, Arnold DL, Collins DL, Narayanan S. Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis. Neuroimage 2020;213:116690.
Dwyer MG, Bergsland N, Ramasamy DP, Jakimovski D, Weinstock-Guttman B, Zivadinov R. Atrophied brain lesion volume: a new imaging biomarker in multiple sclerosis. J Neuroimaging 2018;28:490-5.
Klistorner S, Barnett MH, Yiannikas C, Barton J, Parratt J, You Y, et al. Expansion of chronic lesions is linked to disease progression in relapsing-remitting multiple sclerosis patients. Mult Scler 2021;27:1533-42.
Koch MW, Mostert J, Repovic P, Bowen JD, Strijbis E, Uitdehaag B, et al. MRI brain volume loss, lesion burden, and clinical outcome in secondary progressive multiple sclerosis. Mult Scler 2021 [Online ahead of print]. https://pubmed.ncbi.nlm.nih.gov/34304609/
Healy BC, Buckle GJ, Ali EN, Egorova S, Khalid F, Tauhid S, et al. Characterizing clinical and MRI dissociation in patients with multiple sclerosis. J Neuroimaging 2017;27:481-5.
Bakshi R, Healy BC, Dupuy SL, Kirkish G, Khalid F, Gundel T, et al. Brain MRI predicts worsening multiple sclerosis disability over 5 years in the SUMMIT study. J Neuroimaging 2020;30:212-8.
Dadar M, Narayanan S, Arnold DL, Collins DL, Maranzano J. Conversion of diffusely abnormal white matter to focal lesions is linked to progression in secondary progressive multiple sclerosis. Mult Scler 2021;27:208-19.
Ropele S, Strasser-Fuchs S, Augustin M, Stollberger R, Enzinger C, Hartung HP, et al. A comparison of magnetization transfer ratio, magnetization transfer rate, and the native relaxation time of water protons related to relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol 2000;21:1885-91.
Laule C, Moore GR, Leung E, Michelin E, Whittall KP, MacKay AL, et al. A serial study of dirty white matter in MS (Abstract). Mult Scler 2001;7(Suppl 1):S90.
Vrenken H, Seewann A, Knol DL, Polman CH, Barkhof F, Geurts JJ. Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types. AJNR Am J Neuroradiol 2010;31:541-8.
Laule C, Vavasour IM, Leung E, Li DK, Kozlowski P, Traboulsee AL, et al. Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology. Mult Scler 2011;17:144-50.
Laule C, Leung E, Lis DK, Traboulsee AL, Paty DW, MacKay AL, et al. Myelin water imaging in multiple sclerosis: quantitative correlations with histopathology. Mult Scler 2006;12:747-53.
Weber CE, Nagel K, Ebert A, Roßmanith C, Paschke N, Adlung A, et al. Diffusely appearing white matter in multiple sclerosis: insights from sodium ((23)Na) MRI. Mult Scler Relat Disord 2021;49:102752.
Inglese M, Madelin G, Oesingmann N, Babb JS, Wu W, Stoeckel B, et al. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. Brain 2010;133:847-57.
Zaaraoui W, Konstandin S, Audoin B, Nagel AM, Rico A, Malikova I, et al. Distribution of brain sodium accumulation correlates with disability in multiple sclerosis: a cross-sectional 23Na MR imaging study. Radiology 2012;264:859-67.
Stys PK. General mechanisms of axonal damage and its prevention. J Neurol Sci 2005;233:3-13.
Nagara H, Inoue T, Koga T, Kitaguchi T, Tateishi J, Goto I. Formalin fixed brains are useful for magnetic resonance imaging (MRI) study. J Neurol Sci 1987;81:67-77.
Seewann A, Vrenken H, van der Valk P, Blezer EL, Knol DL, Castelijns JA, et al. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis. Arch Neurol 2009;66:601-9.
Bergers E, Bot JC, van der Valk P, Castelijns JA, Lycklama a Nijeholt GJ, Kamphorst W, et al. Diffuse signal abnormalities in the spinal cord in multiple sclerosis: direct postmortem in situ magnetic resonance imaging correlated with in vitro high-resolution magnetic resonance imaging and histopathology. Ann Neurol 2002;51:652-6.
Moore GR, Laule C, Mackay A, Leung E, Li DK, Zhao G, et al. Dirty-appearing white matter in multiple sclerosis : preliminary observations of myelin phospholipid and axonal loss. J Neurol 2008;255:1802-11.
Laule C, Pavlova V, Leung E, Zhao G, MacKay AL, Kozlowski P, et al. Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration. J Neuropathol Exp Neurol 2013;72:42-52.
Vos CM, Geurts JJ, Montagne L, van Haastert ES, Bö L, van der Valk P, et al. Blood-brain barrier alterations in both focal and diffuse abnormalities on postmortem MRI in multiple sclerosis. Neurobiol Dis 2005;20:953-60.
Zhang Y, Moore GR, Laule C, Bjarnason TA, Kozlowski P, Traboulsee A, et al. Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis. Ann Neurol 2013;74:91-9.
Laule C, Pavlova V, Leung E, Zhao G, Kozlowski P, Traboulsee A, et al. Immune cells in the diffusely abnormal white matter of multiple sclerosis (Abstract). Mult Scler 2014;20(Suppl 1):P576.
Laule C, Kozlowski P, Leung E, Li DK, Mackay AL, Moore GR. Myelin water imaging of multiple sclerosis at 7 T: correlations with histopathology. Neuroimage 2008;40:1575-80.
Sharma S, Laule C, Moore GRW, Li DKB, Zhang Y. Correlating new directional measures of myelin and axonal integrity in T2-weighted MRI with quantitative histology in multiple sclerosis. J Neurosci Methods 2019;311:369-76.
Kutzelnigg A, Lucchinetti CF, Stadelmann C, Brück W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005;128:2705-12.
Lycklama-a-Nijeholt GJ, van Walderveen MA, Castelijns JA, van Waesberghe JH, Polman C, Scheltens P, et al. Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 1998;121:687-97.
Stys PK. Pathoetiology of multiple sclerosis: are we barking up the wrong tree? F1000Prime Rep 2013;5:20-31.
Stys PK, Zamponi GW, van Minnen J, Geurts JJ. Will the real multiple sclerosis please stand up? Nat Rev Neurosci 2012;13:507-14.
Traka M, Podojil JR, McCarthy DP, Miller SD, Popko B. Oligodendrocyte death results in immune-mediated CNS demyelination. Nat Neurosci 2016;19:65-74.
Ludwin SK, Johnson ES. Evidence for a “dying-back” gliopathy in demyelinating disease. Ann Neurol 1981;9:301-5.
Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc 1993;68:627-36.
Stadelmann C, Ludwin S, Tabira T, Guseo A, Lucchinetti CF, Leel-Ossy L, et al. Tissue preconditioning may explain concentric lesions in Baló’s type of multiple sclerosis. Brain 2005;128:979-87.
Aboul-Enein F, Rauschka H, Kornek B, Stadelmann C, Stefferl A, Brück W, et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol 2003;62:25-33.
Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 2008;31:247-69.
Nakahara J, Aiso S, Suzuki N. Autoimmune versus oligodendrogliopathy: the pathogenesis of multiple sclerosis. Arch Immunol Ther Exp (Warsz) 2010;58:325-33.
Rone MB, Cui QL, Fang J, Wang LC, Zhang J, Khan D, et al. Oligodendrogliopathy in multiple sclerosis: low glycolytic metabolic rate promotes oligodendrocyte survival. J Neurosci 2016;36:4698-707.
Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000;47:707-17.
Trapp BD, Quarles RH. Immunocytochemical localization of the myelin-associated glycoprotein. Fact or artifact? J Neuroimmunol 1984;6:231-49.
Trapp BD. Myelin-associated glycoprotein. Location and potential functions. Ann N Y Acad Sci 1990;605:29-43.
Harirchian MH, Rezvanizadeh A, Fakhri M, Oghabian MA, Ghoreishi A, Zarei M, et al. Non-invasive brain mapping of motor-related areas of four limbs in patients with clinically isolated syndrome compared to healthy normal controls. J Clin Neurosci 2010;17:736-41.
Rocca MA, Colombo B, Falini A, Ghezzi A, Martinelli V, Scotti G, et al. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol 2005;4:618-26.
Audoin B, Guye M, Reuter F, Au Duong MV, Confort-Gouny S, Malikova I, et al. Structure of WM bundles constituting the working memory system in early multiple sclerosis: a quantitative DTI tractography study. Neuroimage 2007;36:1324-30.
Miller DH, Thompson AJ, Filippi M. Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 2003;250:1407-19.
Ciccarelli O, Werring DJ, Wheeler-Kingshott CAM, Barker GJ, Parker GJ, Thompson AJ, et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology 2001;56:926-33.
Filippi M. MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment. J Neurol 2015;262:1-6.
Simon JH. MRI outcomes in the diagnosis and disease course of multiple sclerosis. Handb Clin Neurol 2014;122:405-25.